Malaysia has unveiled six strategic initiatives aimed at embedding evidence-based practices, expanding digital tools, and enhancing patient-centered services across its healthcare system. Led by the Malaysian Health Technology Assessment Section (MaHTAS) under the Ministry of Health, these measures mark a significant step in strengthening health policy, evaluation, and delivery nationwide.
The initiatives are designed to modernize Malaysia’s healthcare evaluation and delivery while fostering cross-sector collaboration. Key programs include the revamped MyMaHTAS website for easier access to HTA reports and Clinical Practice Guidelines (CPGs), a Guide to Using Real-World Evidence (RWE) leveraging local electronic medical records, a Public Health Intervention Framework to assess broader societal benefits, and the MaHTAS Assessment Framework for Digital Health Technology (DHT) to evaluate innovations such as telehealth, mobile apps, and AI-powered tools. Additionally, the Ask CPG AI platform provides clinicians with real-time, point-of-care guidance, while a White Paper on Enhancing Medical Device Assessment outlines seven strategic actions aligned with value-based healthcare principles.
By implementing these initiatives, the Ministry of Health aims to position MaHTAS as a recognized regional Center of Excellence, similar to the UK’s National Institute for Health and Care Excellence (NICE). The programs are expected to accelerate evidence-based decision-making in clinical and policy settings, enhance the adoption of digital health technologies, and reinforce Malaysia’s role as a leader in healthcare innovation. The integration of these frameworks and platforms could attract both domestic and international investment in healthcare technology, supporting Malaysia’s ambition to expand its health innovation economy.
(Sources: Malaysia Ministry of Health; Malay Mail)
